Literature Review: Efektivitas, Keamanan, dan Biaya Terapi Imidafenacin untuk Pasien Overactive Bladder
Imidafenacin is a new antimuscarinic agent in Indonesia that was recently approved in 2019 to treat overactive bladder (OAB) symptoms, including urinary incontinence, urinary frequency, and urinary urgency. As a new OAB medication in the Indonesian commercial market, a comprehensive review on the ef...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Indonésio |
| Udgivet: |
Politeknik Kesehatan Tanjung Karang
2020-12-01
|
| Serier: | Jurnal Kesehatan |
| Fag: | |
| Online adgang: | https://ejurnal.poltekkes-tjk.ac.id/index.php/JK/article/view/2256 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|